We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$459B
AUM Growth
+$54.2B
Cap. Flow
+$30.4B
Cap. Flow %
6.63%
Top 10 Hldgs %
17.11%
Holding
10,551
New
1,098
Increased
4,837
Reduced
3,046
Closed
1,108

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.07B
2
TSLA icon
Tesla
TSLA
+$467M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$262M
4
MTCH icon
Match Group
MTCH
+$241M
5
VLO icon
Valero Energy
VLO
+$212M

Sector Composition

Rank Sector Weight
1 Technology 16.89%
2 Financials 8.35%
3 Healthcare 6.45%
4 Consumer Discretionary 5.39%
5 Communication Services 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDS icon
6701
ProShares UltraShort S&P500
SDS
$371M
$58.4K ﹤0.01%
566
-1,388
-71% -$156K
AVTX icon
6702
Avalo Therapeutics
AVTX
$1.04B
$58.3K ﹤0.01%
6,134
+2,551
+71% +$26.3K
HCTI icon
6703
Healthcare Triangle
HCTI
$2.58M
$58K ﹤0.01%
8
+7
+700% +$57.2K
FXA icon
6704
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
$58K ﹤0.01%
847
-8
-0.9% -$531
RAPT
6705
DELISTED
RAPT Therapeutics
RAPT
$58K ﹤0.01%
3,606
+32
+0.9% +$647
ICCC icon
6706
ImmuCell
ICCC
$99.1M
$57.9K ﹤0.01%
15,942
+13,267
+496% +$51.6K
HYFM icon
6707
Hydrofarm Holdings
HYFM
$7.96M
$57.8K ﹤0.01%
8,390
+5,970
+247% +$37K
RVSB icon
6708
Riverview Bancorp
RVSB
$107M
$57.7K ﹤0.01%
12,241
-696
-5% -$3.1K
AEF
6709
abrdn Emerging Markets Equity Income Fund
AEF
$371M
$57.6K ﹤0.01%
10,224
+681
+7% +$3.62K
PSCX icon
6710
Pacer Swan SOS Conservative January ETF
PSCX
$46.5M
$57.4K ﹤0.01%
+2,116
New +$56.4K
QIPT
6711
DELISTED
Quipt Home Medical
QIPT
$57.3K ﹤0.01%
19,634
+6,904
+54% +$21.3K
HTZWW
6712
Hertz Global Holdings Warrants
HTZWW
$102M
$56.9K ﹤0.01%
25,973
-79,168
-75% -$193K
NFGC
6713
New Found Gold
NFGC
$638M
$56.7K ﹤0.01%
22,400
-455
-2% -$1.25K
QBTS icon
6714
D-Wave Quantum Inc. Common Stock
QBTS
$7.53B
$56.6K ﹤0.01%
57,590
+1,046
+2% +$1.05K
ABCL icon
6715
AbCellera Biologics
ABCL
$2.98B
$56.5K ﹤0.01%
21,745
-73,246
-77% -$203K
MCS icon
6716
CALL
Marcus Corp
MCS
$884M
$56.5K ﹤0.01%
3,750
-338,000
-99% -$4.46M
SMC
6717
Summit Midstream
SMC
$479M
$56.5K ﹤0.01%
1,612
-11,431
-88% -$413K
ABOS icon
6718
Acumen Pharmaceuticals
ABOS
$178M
$56.4K ﹤0.01%
22,751
+9,965
+78% +$27K
ACTV
6719
DELISTED
LeaderShares Activist Leaders ETF
ACTV
$56.4K ﹤0.01%
+1,671
New +$54.6K
TECS icon
6720
Direxion Daily Technology Bear 3x ETF
TECS
$63.5M
$56.4K ﹤0.01%
106
-2
-2% -$1.23K
GCAL
6721
Goldman Sachs Dynamic California Municipal Income ETF
GCAL
$177M
$56.2K ﹤0.01%
+1,100
New +$55.8K
CUE icon
6722
Cue Biopharma
CUE
$119M
$56.1K ﹤0.01%
2,473
+506
+26% +$11K
DIBS icon
6723
1stdibs.com
DIBS
$149M
$56.1K ﹤0.01%
12,725
+5,041
+66% +$22.7K
FENC icon
6724
Fennec Pharmaceuticals
FENC
$444M
$56.1K ﹤0.01%
11,223
+3,955
+54% +$22.9K
GWAV icon
6725
Greenwave Technology Solutions
GWAV
$3.52M
$55.9K ﹤0.01%
+1,191
New +$111K

Similar funds

UBS Group's Q3 2024 Portfolio in Review

As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.

  • UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
  • UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
  • UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
  • UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
  • UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
  • UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.